In truth, I don’t anticipate prescribing patterns changing immediately,” cardiologist Vishal Khetpal writes of the new ...

The drug from Merck was OK’d for patients with artery-clogging cholesterol that persists even after taking statins.

For the tens of millions of Americans who cannot push their LDL cholesterol (trivially known as "bad cholesterol") low enough ...

Many think the next standard cancer treatment will pair two innovations: antibody-drug conjugates, or ADCs, and augmented ...

Strong Buy on oncology pipeline gains and LIPFENDRA launch, with KEYTRUDA patent risks. Click for this MRK update.

A newly approved cholesterol-lowering pill could offer millions of people a more convenient way to dramatically reduce "bad" ...

Antibody-drug conjugates from Kelun-Biotech and Hansoh Pharma, respectively partnered with Merck & Co. and GSK, delivered ...

AstraZeneca is paying Sino Biopharmaceutical $200 million upfront for ex-China rights to a late-phase challenger to Merck & Co.’s chronic obstructive pulmonary disease (COPD) drug Ohtuvayre. The deal, ...

Please provide your email address to receive an email when new articles are posted on . The U.S. House Select Committee on China has opened investigations into AbbVie, Bristol Myers Squibb, Eli Lilly, ...

HAMPDEN, Maine (WABI) - A fourth-grade teacher at the Weatherbee School has purchased the rights to a 1980s board game and is relaunching it after his students became hooked on it during the school ...